QuantLogix ← MDLZ scorecard
📅 MDLZ Earnings Preview
MDLZ
Next report (est.)
10/26/2026
Countdown
Imminent
EPS growth YoY
+41.9%
Revenue growth YoY
+8.2%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
04/28/2026 ±2.1% +1.9% over-priced
02/04/2026 ±2.8% -0.1% over-priced
10/28/2025 ±2.1% -2.4% under-priced
07/29/2025 ±1.7% +0.2% over-priced
04/29/2025 ±2.2% +0.8% over-priced
02/05/2025 ±2.2% +2.3% under-priced
10/29/2024 ±1.5% -0.6% over-priced
07/30/2024 ±1.7% -0.1% over-priced
Across these reports, options implied an average ±2.0% move vs an actual average of 1.1% — the stock stayed inside the implied band 75% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q1 FY2026 $0.44 $10.1B $560M
Q4 FY2025 — $10.5B $665M
Q3 FY2025 $0.57 $9.7B $743M
Q2 FY2025 $0.49 $9.0B $641M
Analyst posture
Buy / Strong Buy
21
Hold
10
Sell
0
Stable: +0 net change 30d
Live 5-factor engine read: Buy · 67/100 Full scorecard →
Get alerted before every MDLZ report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on MDLZ before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

MDLZ (MDLZ) reports imminently, with the next report estimated for 10/26/2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 1.1% on average — the market has systematically over-priced MDLZ's earnings risk. Fundamentals into the print: EPS up 41.9% year-over-year, revenue up 8.2%. QuantLogix's live 5-factor engine currently reads MDLZ as a buy at 67/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →